BioAge Labs BIOA
NASDAQ BIOA
$7.06 -0.08 (-1.12%)
As of: Sep 30, 2026 · 3:03 PM EDT

BioAge Labs (BIOA) Non-Current Debt (2023 - 2025)

Updated

BioAge Labs' Non-Current Debt came in at $1.06 million for Q1 2025, down 57.8% from the prior quarter.

Analysis

BioAge Labs (BIOA) Non-Current Debt (2023 - 2025) Analysis & Trends

At the end of FY2024, BioAge Labs' Non-Current Debt was $2.5 million, down 69.5% from FY2023.

  • Going back by year, Non-Current Debt was $8.2 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 37.34 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 62.48 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -108.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 BioAge Labs 326.85 Mn 326.85 Mn -14.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.06 Mn
Dec 31, 2024 2.50 Mn
Sep 30, 2024 3.94 Mn
Dec 31, 2023 8.20 Mn
API Access

BioAge Labs Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BIOA&period=max&api_key=YOUR_API_KEY